We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

DANish Multicenter STENT Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00139802
Recruitment Status : Completed
First Posted : August 31, 2005
Last Update Posted : August 31, 2005
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of the study was to evaluate procedural and late outcome of coronary artery stenting using 2 different unmounted stents

Condition or disease Intervention/treatment Phase
Ischemic Heart Disease Stable Angina Unstable Angina Device: Coronary Stent Implantation Phase 4

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 400 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Low Restenosis Rate of the NIR Coronary Stent: Results of the Danish Multicenter Stent Study (DANSTENT) – a Randomized Study Comparing a First-Generation With a Second-Generation Stent.
Study Start Date : April 1997
Estimated Study Completion Date : June 2001
Arms and Interventions


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Stable, unstable or silent angina,
  • De novo lesion

Exclusion Criteria:

  • Allergy to ticlopidine
  • Recent myocardial infarction
  • Expected survival > 1 year
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00139802


Locations
Denmark
Rigshospitalet
Copenhagen, Denmark, DK-2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Principal Investigator: Henning Kelbaek, MD Rigshospitalet, Denmark
More Information

Publications:
ClinicalTrials.gov Identifier: NCT00139802     History of Changes
Other Study ID Numbers: DANSTENT
First Posted: August 31, 2005    Key Record Dates
Last Update Posted: August 31, 2005
Last Verified: January 1997

Additional relevant MeSH terms:
Heart Diseases
Angina Pectoris
Myocardial Ischemia
Coronary Artery Disease
Angina, Stable
Angina, Unstable
Cardiovascular Diseases
Chest Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Vascular Diseases
Signs and Symptoms
Coronary Disease
Arteriosclerosis
Arterial Occlusive Diseases